CD8A and neoplasm: Currently, multiple potential factors have been identified, including the tumour mutation burden (TMB),6 MSI status,7 neoepitope load,8 PD‐L1 level,9 CD8 + T‐cell density,10 interferon‐γ gene signature,11 and MHC and T‐cell receptor repertoire.12